Homeopathic Drug Product Safety, Quality, and Transparency Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 7
- Latest action
- Jan 14, 2026
What it does
The Homeopathic Drug Product Safety, Quality, and Transparency Act would amend the Federal Food, Drug, and Cosmetic Act to establish a distinct regulatory pathway for homeopathic drug products, defining them as drugs containing only homeopathic ingredients listed in recognized pharmacopoeias or prepared under accredited standards. It would exempt these products from most standard drug regulations—including requirements for identity and strength testing of active ingredients—while imposing alternative safety, quality, and labeling requirements based on homeopathic pharmacopoeial or consensus standards, and allowing petitions for exemptions from manufacturing practices if safety is not…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.